NCT00335010

Brief Summary

The aim of the present study was to investigate if NTG, administered intravenously during gastric tube reconstruction, could preserve gastric fundus tissue blood flow and oxygenation and reduce the incidence of postoperative leakage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2005

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 8, 2006

Completed
Last Updated

June 8, 2006

Status Verified

June 1, 2006

First QC Date

June 7, 2006

Last Update Submit

June 7, 2006

Conditions

Keywords

Nitroglycerinegastroesophageal anastomosismicrovascular bloodflowmicrovascular hemoglobinsaturation

Outcome Measures

Primary Outcomes (2)

  • differences in Microvascular bloodflow

  • differences in microvascular hemoglobinsaturation

Secondary Outcomes (2)

  • differences in anastomotic leakage

  • differences in anastomotic stenosis

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Planned esophagectomy with gastric tube reconstruction
  • written informed consent
  • ASA I and II

You may not qualify if:

  • younger than 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus MC

Rotterdam, 3000ZA, Netherlands

Location

Related Publications (5)

  • Buise MP, Ince C, Tilanus HW, Klein J, Gommers D, van Bommel J. The effect of nitroglycerin on microvascular perfusion and oxygenation during gastric tube reconstruction. Anesth Analg. 2005 Apr;100(4):1107-1111. doi: 10.1213/01.ANE.0000147665.60613.CA.

    PMID: 15781529BACKGROUND
  • Pierie JP, de Graaf PW, van Vroonhoven TJ, Obertop H. Healing of the cervical esophagogastrostomy. J Am Coll Surg. 1999 Apr;188(4):448-54. doi: 10.1016/s1072-7515(99)00003-4. No abstract available.

    PMID: 10195730BACKGROUND
  • Jacobi CA, Zieren HU, Zieren J, Muller JM. Is tissue oxygen tension during esophagectomy a predictor of esophagogastric anastomotic healing? J Surg Res. 1998 Feb 1;74(2):161-4. doi: 10.1006/jsre.1997.5239.

    PMID: 9587355BACKGROUND
  • Siegemund M, van Bommel J, Ince C. Assessment of regional tissue oxygenation. Intensive Care Med. 1999 Oct;25(10):1044-60. doi: 10.1007/s001340051011. No abstract available.

    PMID: 10551958BACKGROUND
  • Buise M, van Bommel J, Jahn A, Tran K, Tilanus H, Gommers D. Intravenous nitroglycerin does not preserve gastric microcirculation during gastric tube reconstruction: a randomized controlled trial. Crit Care. 2006;10(5):R131. doi: 10.1186/cc5043.

MeSH Terms

Conditions

Esophageal Neoplasms

Interventions

Nitroglycerin

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Intervention Hierarchy (Ancestors)

Nitro CompoundsOrganic Chemicals

Study Officials

  • Diederik Gommers, MD, PhD

    Erasmus Medical Center

    STUDY CHAIR
  • Marc Buise, MD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR
  • Jasper van Bommel, MD, PhD

    Erasmus Medical Center

    STUDY DIRECTOR
  • Huug Tilanus, MD, PhD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR
  • Khe Tran, MD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 7, 2006

First Posted

June 8, 2006

Study Start

May 1, 2005

Study Completion

December 1, 2005

Last Updated

June 8, 2006

Record last verified: 2006-06

Locations